z-logo
open-access-imgOpen Access
IP6K2 predicts favorable clinical outcome of primary breast cancer
Author(s) -
Josefine Sandström,
A. Balian,
Rebecca Lockowandt,
Tommy� Fornander,
Bo Nordenskjöld,
Linda S. Lindström,
G. Pérez-Tenorio,
Olle Stål
Publication year - 2021
Publication title -
molecular and clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.442
H-Index - 7
eISSN - 2049-9469
pISSN - 2049-9450
DOI - 10.3892/mco.2021.2256
Subject(s) - breast cancer , oncogene , cancer , oncology , biology , pi3k/akt/mtor pathway , protein kinase b , medicine , cohort , molecular medicine , cancer research , gene , gene expression , bioinformatics , cell cycle , apoptosis , genetics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom